Carolina Blood and Cancer Care Associates

Lancaster, South Carolina 29732

0 studies enrolling now · 2 studies all time

What they study most

Primary Invasive Breast Cancer, Progressive Brain Metastasis, Unresectable or Metastatic Melanoma

Studies at this site

• Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma — Running, not enrolling
• EndoPredict® Extended Endocrine Trial (EXET) — Stopped early